Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Cost of Revenue (2017 - 2025)

MedWellAI (MWAI) has disclosed Cost of Revenue for 9 consecutive years, with $250.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue changed N/A to $250.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $83604.0, a 104.16% increase, with the full-year FY2025 number at $65030.0, changed N/A from a year prior.
  • Cost of Revenue was $250.0 for Q4 2025 at MedWellAI, down from $18324.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.2 million in Q1 2024 to a low of -$3.2 million in Q2 2024.
  • A 5-year average of $338313.0 and a median of $768892.0 in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 467.66% in 2021, then crashed 238.82% in 2023.
  • MedWellAI's Cost of Revenue stood at $811398.0 in 2021, then dropped by 16.36% to $678690.0 in 2022, then surged by 72.65% to $1.2 million in 2023, then plummeted by 373.87% to -$3.2 million in 2024, then surged by 100.01% to $250.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Cost of Revenue are $250.0 (Q4 2025), $18324.0 (Q3 2025), and $65030.0 (Q2 2025).